E. Yeh

University of Toronto

Author Of 3 Presentations

Pediatric MS Oral Presentation

PS07.04 - Fibre-specific white matter differences in children with pediatric acquired demyelinating syndromes compared to healthy children

Speakers
Presentation Number
PS07.04
Presentation Topic
Pediatric MS
Lecture Time
13:27 - 13:39

Abstract

Background

White matter (WM) microstructural changes occur in youth with multiple sclerosis (MS) and myelin oligodendrocyte glyoprotein (MOG)-associated disorders. While diffusion tensor imaging has been extensively used to characterize white matter, this method lacks microstructural and pathological specificity. ‘Fixel Based Analysis’ (FBA) statistically estimates changes in diffusion MRI connectivity that is specific to micro and macro-structure. WM damage that leads to less densely packed axons in a fiber bundle causes a decrease in fibre density (FD). If the number of axons is not reduced but occupies less area, then fibre cross-section (FC) will decrease. Last, if the density of axons within a fibre bundle and the area the bundle occupies are reduced, then fibre density and cross-section (FDC) will decrease.

Objectives

To use whole-brain FBA to measure differences in FD, FC, FDC in youth with demyelinating syndromes compared to healthy controls.

Methods

We evaluated group differences in the FBA metrics between 28 typically developing children (17F; age 15.0±2.6y), 19 children with MS (13F; 16.9±1.1y; disease duration (DD)=0.1-11.7y; expanded disability status scale(EDSS):median=1.5,range=0-4.5), and 11 children with MOG (8F;12.1±2.8y; DD=0.5-6.4y;EDSS:m=1.0,r=0-3). Multi-shell diffusion-weighted imaging of the brain was acquired with echo planar imaging on a 3T MRI scanner and was pre-processed to correct for distortions and movement. Whole-brain group FBA was performed on FD, FC and FDC to test differences between groups adjusting for age, sex, total intracranial volume, EDSS and DD (p<0.05, family-wise error (FWE) corrected).

Results

Participants with MS and MOG showed reduced FD, FC and FDC relative to typically developing children (FWE corrected p<0.05). Differences in FD were found within splenium, superior longitudinal fasciculus and optic radiations. MS patients had reduced FDC within the corticospinal tract and cerebellar peduncle compared to MOG patients. In participants with MS and MOG, decreased FD within the brain stem, cerebellar peduncles and corona radiata was associated with increased DD and EDSS.

Conclusions

Our preliminary findings showed that patients with demyelinating disorders display decreased axonal density and fibre bundle size in multiple WM tracts relative to typically developing children, which were related to clinical outcomes (EDSS, DD). These changes were more pronounced in MS compared to MOG participants in selected WM tracts.

Collapse
Microbiome Oral Presentation

PS10.03 - Functional survey of the pediatric multiple sclerosis microbiome        

Speakers
Presentation Number
PS10.03
Presentation Topic
Microbiome
Lecture Time
09:45 - 09:57

Abstract

Background

Metagenomic sequencing reveals the functional potential of the gut microbiome, and may explain how the gut microbiome influences pediatric-onset multiple sclerosis (MS) risk.

Objectives

To examine the gut microbiome functional potential by metagenomic analysis of stool samples from pediatric MS cases and controls using a case-control design.

Methods

Persons ≤21 years old enrolled in the Canadian Pediatric Demyelinating Disease Network who provided a stool sample and were not exposed to antibiotics or corticosteroids 30 days prior were included for study. All MS cases met McDonald criteria, had symptom onset <18 years of age and had either no prior disease-modifying drug (DMD) exposure or were exposed to beta-interferon or glatiramer acetate only. Twenty MS cases were matched to 20 non-affected controls by sex, age (± 3 years), stool consistency (Bristol Stool Scale, BSS) and, when possible, by race. Shotgun metagenomic reads were generated using the Illumina NextSeq platform and assembled using MEGAHIT. Metabolic pathway analysis was used to compare the gut microbiome between cases and controls, as well as cases by DMD status (DMD naïve vs DMD exposed MS cases vs controls). Gene ontology classifications were used to assess α-diversity and differential abundance analyses (based on the negative binomial distribution) reported as age-adjusted log-fold change (LFC) in relative abundance, 95% confidence intervals (CI), and false discovery rate adjusted p-values.

Results

The MS cases were aged 13.6 mean years at symptom onset. On average, MS cases and controls were 16.1 and 15.4 years old at the time of stool collection and 80% of each group were girls. MS cases and controls were similar for body mass index (median: 22.8 and 21.0, respectively), stool consistency (BSS types 1-2: n=4, types 3-5: n=16, for both MS and controls) and race (Caucasian: 11 and 9, respectively). Eight MS cases were DMD naïve. Richness of gene ontology classifications did not differ by disease status or DMD status (all p>0.4). However, differential analysis of metabolic pathways indicated that the relative abundance of tryptophan degradation (via the kynurenine pathway; LFC 13; 95%CI: 8–19; p<0.0005) and cresol degradation (LFC 19; 95%CI: 13–25; p<0.0001) pathways were enriched for MS cases vs controls. Differences by DMD status were also observed, e.g., choline biosynthesis was enriched in DMD exposed vs naïve MS cases (LFC 21; 95%CI: 12–29; p<0.0001).

Conclusions

We observed differences in the functional potential of the gut microbiome of young individuals with MS relative to controls at various metabolic pathways, including enrichment of pathways related to tryptophan and metabolism of industrial chemicals. DMD exposure affected findings, with enrichment of pathways involved in promoting CNS remyelination (e.g., choline).

Collapse
Machine Learning/Network Science Oral Presentation

PS16.03 - Use of machine learning classifiers based on structural and functional visual metrics to predict diagnosis in children with acquired demyelination.

Speakers
Presentation Number
PS16.03
Presentation Topic
Machine Learning/Network Science
Lecture Time
13:15 - 13:27

Abstract

Background

Predicting diagnosis in youth at the first episode of demyelination is feasible in some but not all cases. Machine learning classifiers (MLC) can be trained to identify relationships between numerous multimodal input features and disease classifications to provide highly accurate predictions.

Objectives

To assess performance of machine learning classifiers for early disease diagnosis based on visual metrics in youth with demyelination.

Methods

Standardized clinical and visual data was prospectively collected at disease onset from 141 pediatric subjects with acquired demyelinating syndromes (ADS) and 75 healthy controls (HC). Participants were recruited through The Hospital for Sick Children (Toronto, Ontario (2010-2020)) and University of Calgary (2010-2017). Patients were classified using consensus definitions of demyelinating disorders and serum antibody testing for myelin oligodendrocyte glycoprotein (MOG) and aquaporin 4 (AQP4). Twenty-two auto-segmented Optical Coherence Tomography (OCT) features, 4 functional visual and 4 clinical features were used in a stratified manner alone or in combination to identify which combination of features provided the highest predictive accuracy. These input features were analyzed using 9 supervised MLC (Random Forest (RF), AdaBoost, XGBoost, Decision Tree (DT), Logistic Regression, Support Vector Machines (SVM), k-Nearest Neighbors, Stochastic Gradient Descent, Multinomial Naive Bayes). Data was split 80/20 between training and test sets. Backward feature selection was performed to re-run the analysis with best scoring predictor features in the MLC with highest predictive accuracy.

Results

AdaBoost, SVM, and DT were the best performing MLC with a test set accuracy between 82-88% in distinguishing between ADS and HC eyes. Multiple sclerosis (MS) was distinguished from HC with 92% accuracy. In descending order, fovea thickness, inferotemporal ganglion cell layer (GCL) thickness, low contrast visual acuity, outer inferior macular thickness, temporal peripapillary retinal nerve fiber layer and superior GCL thicknesses were the most important contributors to disease classification.

Conclusions

MLC can be used to combine visual metrics and clinical parameters to distinguish ADS from HC, and to predict MS. In addition to commonly used clinical metrics, we identified other structural and functional metrics that contribute importantly to classification. Among the machine learning algorithms tested, AdaBoost, SVM and DT performed best for this model.

Collapse

Moderator Of 1 Session

Hot Topics Sun, Sep 13, 2020
Moderators
Session Type
Hot Topics
Date
Sun, Sep 13, 2020
Time (ET)
09:15 - 10:00